Stuart A Arbuckle - Net Worth and Insider Trading

Stuart A Arbuckle Net Worth

The estimated net worth of Stuart A Arbuckle is at least $24 Million dollars as of 2024-11-13. Stuart A Arbuckle is the EVP, COO of Vertex Pharmaceuticals Inc and owns about 49,831 shares of Vertex Pharmaceuticals Inc (VRTX) stock worth over $24 Million. Details can be seen in Stuart A Arbuckle's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stuart A Arbuckle has not made any transactions after 2024-02-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Stuart A Arbuckle

To

Stuart A Arbuckle Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stuart A Arbuckle owns 4 companies in total, including Vertex Pharmaceuticals Inc (VRTX) , Immunogen Inc (IMGN) , and Rhythm Pharmaceuticals Inc (RYTM) among others .

Click here to see the complete history of Stuart A Arbuckle’s form 4 insider trades.

Insider Ownership Summary of Stuart A Arbuckle

Ticker Comapny Transaction Date Type of Owner
VRTX Vertex Pharmaceuticals Inc 2024-02-26 EVP & COO
IMGN Immunogen Inc 2018-01-23 director
RYTM Rhythm Pharmaceuticals Inc 2019-07-23 director
LIMIT LIMIT 2015-06-26 director

Stuart A Arbuckle Latest Holdings Summary

Stuart A Arbuckle currently owns a total of 1 stock. Stuart A Arbuckle owns 49,831 shares of Vertex Pharmaceuticals Inc (VRTX) as of February 26, 2024, with a value of $24 Million.

Latest Holdings of Stuart A Arbuckle

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
VRTX Vertex Pharmaceuticals Inc 2024-02-26 49,831 490.00 24,417,190

Holding Weightings of Stuart A Arbuckle


Stuart A Arbuckle Form 4 Trading Tracker

According to the SEC Form 4 filings, Stuart A Arbuckle has made a total of 34 transactions in Vertex Pharmaceuticals Inc (VRTX) over the past 5 years, including 0 buys and 34 sells. The most-recent trade in Vertex Pharmaceuticals Inc is the sale of 5,034 shares on February 26, 2024, which brought Stuart A Arbuckle around $2 Million.

Insider Trading History of Stuart A Arbuckle

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Stuart A Arbuckle Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Stuart A Arbuckle Ownership Network

Ownership Network List of Stuart A Arbuckle

No Data

Ownership Network Relation of Stuart A Arbuckle

Insider Network Chart

Stuart A Arbuckle Owned Company Details

What does Vertex Pharmaceuticals Inc do?

Who are the key executives at Vertex Pharmaceuticals Inc?

Stuart A Arbuckle is the EVP & COO of Vertex Pharmaceuticals Inc. Other key executives at Vertex Pharmaceuticals Inc include EVP and Chief Legal Officer Jonathan Biller , EVP and CMO Carmen Bozic , and director & CEO & President Reshma Kewalramani .

Vertex Pharmaceuticals Inc (VRTX) Insider Trades Summary

Over the past 18 months, Stuart A Arbuckle made 7 insider transaction in Vertex Pharmaceuticals Inc (VRTX) with a net sale of 35,024. Other recent insider transactions involving Vertex Pharmaceuticals Inc (VRTX) include a net sale of 47,585 shares made by Carmen Bozic , a net sale of 16,533 shares made by Ourania Tatsis , and a net sale of 77,232 shares made by Reshma Kewalramani .

In summary, during the past 3 months, insiders sold 5,429 shares of Vertex Pharmaceuticals Inc (VRTX) in total and bought 0 shares, with a net sale of 5,429 shares. During the past 18 months, 340,041 shares of Vertex Pharmaceuticals Inc (VRTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 340,041 shares.

Vertex Pharmaceuticals Inc (VRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Vertex Pharmaceuticals Inc Insider Transactions

No Available Data

Stuart A Arbuckle Mailing Address

Above is the net worth, insider trading, and ownership report for Stuart A Arbuckle. You might contact Stuart A Arbuckle via mailing address: Vertex Pharmaceuticals Incorporated, 130 Waverly St., Cambridge Ma 02139.